InvestorsHub Logo

nh

Followers 24
Posts 1600
Boards Moderated 0
Alias Born 05/27/2005

nh

Re: slipperypete post# 16483

Monday, 08/20/2007 12:29:46 PM

Monday, August 20, 2007 12:29:46 PM

Post# of 346720
Ok, let's compare PPHM and ALNY, since you want to continue this conversation. They're sort of in the same space, different technologies tackling some similar disease processes / targets. I'm not trying to pump ALNY, only trying to make a point. I do not own ALNY. I would like very much to see PPHM's technogy suceed and am a long term investor.

Here's a recent quote from a PR:
"In July, the company said Switzerland-based Roche licensed rights to Alnylam's gene-silencing technology. Roche is required to make aggregate payments to Alnylam of about $331 million including an upfront cash payment within 10 days of the closing. The Roche Venture Fund also bought about $42.5 million in Alnylam common stock"

In fact, just follow this link to see headlines of some of the deals they've made.

http://finance.yahoo.com/q/h?s=ALNY&t=2007-08-09T16:58:34-04:00

Now, ALNY hasn't issued new shares in quite some time (I can't remember the last time, sorry). Here are some statistics:
Shares Outstanding: 37.69M
Float: 31.74M
% Held by Insiders: 0.01%
% Held by Institutions: 51.50%

I don't think we have to give away the farm, we just have to demonstrate the value of the technology, good stewardship of money, and good stewardship of the technology. I believe we are demonstrating the first one, it's the last two that are troubling. Many people do not know how to manage money well and until they need to learn how, they don't.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News